These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6317272

  • 1. Effect of protein binding on cefmenoxime steady-state kinetics in critical patients.
    Reitberg DP, Cumbo TJ, Smith IL, Schentag JJ.
    Clin Pharmacol Ther; 1984 Jan; 35(1):64-73. PubMed ID: 6317272
    [Abstract] [Full Text] [Related]

  • 2. Cefmenoxime efficacy, safety, and pharmacokinetics in critical care patients with nosocomial pneumonia.
    Schentag JJ, Reitberg DP, Cumbo TJ.
    Am J Med; 1984 Dec 21; 77(6A):34-42. PubMed ID: 6097122
    [Abstract] [Full Text] [Related]

  • 3. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA, Polk RE, Kerkering TM, Patterson P, Baggett J.
    Eur J Clin Pharmacol; 1986 Dec 21; 30(6):713-7. PubMed ID: 3464435
    [Abstract] [Full Text] [Related]

  • 4. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
    Gambertoglio JG, Alexander DP, Barriere SL.
    Antimicrob Agents Chemother; 1984 Dec 21; 26(6):845-9. PubMed ID: 6098220
    [Abstract] [Full Text] [Related]

  • 5. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
    Polk RE, Sica DA, Kerkering TM, Kline BJ, Patterson PM, Baggett JW.
    Antimicrob Agents Chemother; 1984 Sep 21; 26(3):322-7. PubMed ID: 6095752
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K.
    Antimicrob Agents Chemother; 1986 Dec 21; 30(6):901-5. PubMed ID: 3468882
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I, Shirakawa Y, Fugono T.
    J Antibiot (Tokyo); 1981 Nov 21; 34(11):1476-85. PubMed ID: 6274834
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P, Bryskier A, Modai J, Boquet A, Fourtillan JB.
    Pathol Biol (Paris); 1986 Dec 21; 34(10):1081-3. PubMed ID: 3547264
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
    Yamazaki I, Shirakawa Y, Fugono T.
    J Antibiot (Tokyo); 1981 Aug 21; 34(8):1055-63. PubMed ID: 6274837
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
    Pangon B, Joly V, Vallois JM, Abel L, Buré A, Brion N, Contrepois A, Carbon C.
    Antimicrob Agents Chemother; 1987 Apr 21; 31(4):518-22. PubMed ID: 3300530
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D, Koeppe P.
    Arzneimittelforschung; 1983 Apr 21; 33(2):269-72. PubMed ID: 6303362
    [Abstract] [Full Text] [Related]

  • 12. Effect of probenecid on the pharmacokinetics of cefmenoxime.
    Sennello LT, Quinn D, Rollins DE, Tolman KG, Sonders RC.
    Antimicrob Agents Chemother; 1983 Jun 21; 23(6):803-7. PubMed ID: 6311084
    [Abstract] [Full Text] [Related]

  • 13. Cefmenoxime in the treatment of nosocomial pneumonias in critical care patients.
    Reitberg DP, Cumbo TJ, Schentag JJ.
    J Antimicrob Chemother; 1984 Jul 21; 14(1):81-91. PubMed ID: 6090380
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB, Bryskier A, Mignot A, Borsa F, Humbert G.
    Am J Med; 1984 Dec 21; 77(6A):28-31. PubMed ID: 6097120
    [Abstract] [Full Text] [Related]

  • 15. Age and ceftriaxone kinetics.
    Luderer JR, Patel IH, Durkin J, Schneck DW.
    Clin Pharmacol Ther; 1984 Jan 21; 35(1):19-25. PubMed ID: 6317271
    [Abstract] [Full Text] [Related]

  • 16. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM, Todd PA.
    Drugs; 1987 Aug 21; 34(2):188-221. PubMed ID: 3304966
    [Abstract] [Full Text] [Related]

  • 17. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR, Sennello LT, Steinberg FJ, Sonders RC.
    Antimicrob Agents Chemother; 1982 Jan 21; 21(1):141-5. PubMed ID: 6282203
    [Abstract] [Full Text] [Related]

  • 18. Liquid-chromatographic assay of cefmenoxime in serum and urine.
    Reitberg DP, Schentag JJ.
    Clin Chem; 1983 Jul 21; 29(7):1415-8. PubMed ID: 6305536
    [Abstract] [Full Text] [Related]

  • 19. Role for dual individualization with cefmenoxime.
    Schentag JJ, Smith IL, Swanson DJ, DeAngelis C, Fracasso JE, Vari A, Vance JW.
    Am J Med; 1984 Dec 21; 77(6A):43-50. PubMed ID: 6097124
    [Abstract] [Full Text] [Related]

  • 20. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR, Abraham PA, Halstenson CE, Keane WF.
    Clin Pharmacol Ther; 1985 Jul 21; 38(1):31-6. PubMed ID: 4006373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.